Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Cerebos Pacific, SATS, Tuan Sing: Singapore Stocks Preview

Feb. 2 (Bloomberg) -- The following companies may have unusual price changes in Singapore trading. Stock symbols are in parentheses, and share prices are from the previous close.

Singapore’s Straits Times Index gained 0.2 percent 3,184.74.

Cerebos Pacific Ltd. (CER SP): The maker of Brand’s Essence of Chicken health tonic said net income in the three months ended December rose 16 percent to S$42.6 million from a year earlier. The shares lost 1.2 percent to S$4.87.

SATS Ltd. (SATS SP): The ground-handling services provider partly owned by Temasek Holdings Pte said fiscal third-quarter profit fell 4.1 percent to S$51.2 million from a year earlier. SATS rose 0.7 percent to S$2.80.

Singapore Exchange Ltd. (SGX SP): Operator of the city’s derivatives and securities exchange said its initial public offering capitalization jumped five-fold in 2010 from a year earlier. There were 39 new IPOs last year, compared with 29 in 2009, it said. The stock slid 0.7 percent to S$8.40.

Tuan Sing Holdings Ltd. (TSH SP): The property developer and construction company said fourth-quarter net income increased 60 percent to S$37.3 million from a year earlier. Tuan Sing gained 3.3 percent to 31 Singapore cents.

To contact the reporter on this story: Jonathan Burgos in Singapore at jburgos4@bloomberg.net.

To contact the editor responsible for this story: Nicolas Johnson at nicojohnson@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.